144
Views
11
CrossRef citations to date
0
Altmetric
Original Research

Clinicopathological and prognostic significance of CDH1 hypermethylation in hepatocellular carcinoma: a meta-analysis

, , , , , & show all
Pages 857-864 | Published online: 17 Jan 2019

References

  • AlacaciogluASomaliISimsekIEpidemiology and survival of hepatocellular carcinoma in Turkey: outcome of multicenter studyJpn J Clin Oncol2008381068368818753360
  • VillanuevaAMinguezBFornerAReigMLlovetJMHepatocellular carcinoma: novel molecular approaches for diagnosis, prognosis, and therapyAnnu Rev Med20106131732820059340
  • YangJDRobertsLRHepatocellular carcinoma: A global viewNat Rev Gastroenterol Hepatol20107844845820628345
  • TakeichiMCadherins: a molecular family essential for selective cell-cell adhesion and animal morphogenesisTrends Genet198738213217
  • TakeichiMHattaKNoseANagafuchiAIdentification of a gene family of cadherin cell adhesion moleculesCell Differ Dev198825Suppl91943061598
  • GumbinerBStevensonBGrimaldiAThe role of the cell adhesion molecule uvomorulin in the formation and maintenance of the epithelial junctional complexJ Cell Biol19881074157515873049625
  • GumbinerBMRegulation of cadherin-mediated adhesion in morphogenesisNat Rev Mol Cell Biol20056862263416025097
  • TakeichiMCadherin cell adhesion receptors as a morphogenetic regulatorScience19912515000145114552006419
  • MareelMBoterbergTNoëVE-cadherin/catenin/cyto-skeleton complex: a regulator of cancer invasionJ Cell Physiol199717322712749365535
  • PaduaDMassaguéJRoles of TGFbeta in metastasisCell Res20091918910219050696
  • QianXKarpovaTSheppardAMMcnallyJLowyDRE-cadherin-mediated adhesion inhibits ligand-dependent activation of diverse receptor tyrosine kinasesEmbo J20042381739178415057284
  • OzawaMBaribaultHKemlerRThe cytoplasmic domain of the cell adhesion molecule uvomorulin associates with three independent proteins structurally related in different speciesEmbo J198986171117172788574
  • MendonsaAMNaTYGumbinerBME-cadherin in contact inhibition and cancerOncogene201837354769478029780167
  • GiannelliGKoudelkovaPDituriFMikulitsWRole of epithelial to mesenchymal transition in hepatocellular carcinomaJ Hepatol201665479880827212245
  • YoshiuraKKanaiYOchiaiAShimoyamaYSugimuraTHirohashiSSilencing of the E-cadherin invasion-suppressor gene by CpG methylation in human carcinomasProc Natl Acad Sci U S A19959216741674197543680
  • GraffJRHermanJGLapidusRGE-cadherin expression is silenced by DNA hypermethylation in human breast and prostate carcinomasCancer Res19955522519551997585573
  • HuangJCurrent progress in epigenetic research for hepatocarcinomagenesisSci China C Life Sci2009521314219152082
  • YangBGuoMHermanJGClarkDPAberrant promoter methylation profiles of tumor suppressor genes in hepatocellular carcinomaAm J Pathol200316331101110712937151
  • WellsGASheaBO’ConnellDThe Newcastle-Ottawa Scale (NOS) for Assessing the Quality of Nonrandomised Studies in Meta-AnalysesOttawa, ONOttawa Hospital Research Institute2013
  • GyorffyBSurowiakPBudcziesJLanczkyAOnline survival analysis software to assess the prognostic value of biomarkers using transcriptomic data in non-small-cell lung cancerPLoS One8e82241
  • EggerMDavey SmithGSchneiderMMinderCBias in meta-analysis detected by a simple, graphical testBMJ199731571096296349310563
  • van RoyFBerxGThe cell-cell adhesion molecule E-cadherinCell Mol Life Sci200865233756378818726070
  • BerxGvan RoyFInvolvement of members of the cadherin superfamily in cancerCold Spring Harb Perspect Biol200916a00312920457567
  • RodriguezFJLewis-TuffinLJAnastasiadisPZE-cadherin’s dark side: possible role in tumor progressionBiochim Biophys Acta201218261233122440943
  • KanaiYUshijimaSHuiAMThe E-cadherin gene is silenced by CpG methylation in human hepatocellular carcinomasInt J Cancer19977133553599139867
  • SchagdarsurenginUWilkensLSteinemannDFrequent epigenetic inactivation of the RASSF1A gene in hepatocellular carcinomaOncogene200322121866187112660822
  • OhBKKimHParkHJDNA methyltransferase expression and DNA methylation in human hepatocellular carcinoma and their clinicopathological correlationInt J Mol Med2007201657317549390
  • SaitoYKanaiYNakagawaTIncreased protein expression of DNA methyltransferase (DNMT) 1 is significantly correlated with the malignant potential and poor prognosis of human hepatocellular carcinomasInt J Cancer2003105452753212712445
  • BeumerJHPariseRANewmanEMConcentrations of the DNA methyltransferase inhibitor 5-fluoro-2′-deoxycytidine (FdCyd) and its cytotoxic metabolites in plasma of patients treated with FdCyd and tetrahydrouridine (THU)Cancer Chemother Pharmacol200862236336817899082
  • GowherHJeltschAMechanism of inhibition of DNA methyl-transferases by cytidine analogs in cancer therapyCancer Biol Ther20043111062106815539938
  • NewmanEMMorganRJKummarSA phase I, pharmacokinetic, and pharmacodynamic evaluation of the DNA methyltransferase inhibitor 5-fluoro-2′-deoxycytidine, administered with tetrahydrouridineCancer Chemother Pharmacol201575353754625567350
  • GiannelliGBergaminiCFransveaESgarraCAntonaciSLaminin-5 with transforming growth factor-beta1 induces epithelial to mesenchymal transition in hepatocellular carcinomaGastroenterology200512951375138316285938
  • GaoDVahdatLTWongSChangJCMittalVMicroenvironmental regulation of epithelial-mesenchymal transitions in cancerCancer Res201272194883488923002209
  • LeeTKPoonRTYuenAPTwist overexpression correlates with hepatocellular carcinoma metastasis through induction of epithelial-mesenchymal transitionClin Cancer Res200612185369537617000670
  • ZekriARBahnasyAAShoeabFEMethylation of multiple genes in hepatitis C virus associated hepatocellular carcinomaJ Adv Res201451274025685469
  • HerathNIPurdieDMKewMCVarying etiologies lead to different molecular changes in Australian and South African hepatocellular carcinomasInt J Oncol20093551081108919787262
  • NishidaNNagasakaTNishimuraTIkaiIBolandCRGoelAAberrant methylation of multiple tumor suppressor genes in aging liver, chronic hepatitis, and hepatocellular carcinomaHepatology200847390891818161048
  • KatohHShibataTKokubuAEpigenetic instability and chromosomal instability in hepatocellular carcinomaAm J Pathol200616841375138416565510
  • YuanYWangJLiJFrequent epigenetic inactivation of spleen tyrosine kinase gene in human hepatocellular carcinomaClin Cancer Res200612226687669517121887
  • KwonGYYooBCKohKCChoJWParkWSParkCKPromoter methylation of E-cadherin in hepatocellular carcinomas and dysplastic nodulesJ Korean Med Sci200520224224715831995
  • HerathNIWalshMDKewMCYoungJLeggettBAMacdonaldGACadherin/catenin complex appears to be intact in hepatocellular carcinomas from Australia and South AfricaJ Gastroenterol Hepatol200419667668215151624
  • LeeSLeeHJKimJHLeeHSJangJJKangGHAberrant CpG island hypermethylation along multistep hepatocarcinogenesisAm J Pathol200316341371137814507645
  • MatsumuraTMakinoRMitamuraKFrequent down-regulation of E-cadherin by genetic and epigenetic changes in the malignant progression of hepatocellular carcinomasClin Cancer Res20017359459911297254